|
1
|
Liao LM, Zhang X, Ren YF, et al:
Chromogranin A (CgA) as poor prognostic factor in patients with
small cell carcinoma of the cervix: results of a retrospective
study of 293 patients. PLoS One. 7:e336742012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Delaloge S, Pautier P, Kerbrat P, et al:
Neuroendocrine small cell carcinoma of the uterine cervix: what
disease? What treatment? Report of ten cases and a review of the
literature. Clin Oncol (R Coll Radiol). 12:357–362. 2000.
View Article : Google Scholar
|
|
3
|
Zivanovic O, Leitao MM Jr, Park KJ, et al:
Small cell neuroendocrine carcinoma of the cervix: Analysis of
outcome, recurrence pattern and the impact of platinum-based
combination chemotherapy. Gynecol Oncol. 112:590–593. 2009.
View Article : Google Scholar
|
|
4
|
FIGO Committee on Gynecologic Oncology.
FIGO staging for carcinoma of the vulva, cervix, and corpus uteri.
Int J Gynaecol Obstet. 125:97–98. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li JD, Zhuang Y, Li YF, et al: A
clinicopathological aspect of primary small-cell carcinoma of the
uterine cervix: a single-centre study of 25 cases. Clin Pathol.
64:1102–1107. 2011. View Article : Google Scholar
|
|
6
|
Kuji S, Hirashima Y, Nakayama H, et al:
Diagnosis, clinicopathologic features, treatment, and prognosis of
small cell carcinoma of the uterine cervix: Kansai Clinical
Oncology Group/Intergroup study in Japan. Gynecol Oncol.
129:522–527. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cohen JG, Kapp DS, Shin JY, et al: Small
cell carcinoma of the cervix: treatment and survival outcomes of
188 patients. Obstet Am J Obstet Gynecol. 203:347.e1–e6. 2010.
|
|
8
|
Lindel K, Burri P, Studer HU, et al: Human
papillomavirus status in advanced cervical cancer: predictive and
prognostic significance for curative radiation treatment. Int J
Gynecol Cancer. 15:278–284. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vosmik M, Laco J, Sirak I, et al:
Prognostic Significance of human papillomavirus (HPV) status and
expression of selected markers (HER2/neu, EGFR, VEGF, CD34, p63,
p53 and Ki67/MIB-1) on outcome after (chemo-) radiotherapy in
patients with squamous cell carcinoma of uterine cervix. Pathol
Oncol Res. 20:131–137. 2014. View Article : Google Scholar
|
|
10
|
Sood AK, Sorosky JI, Mayr N, et al:
Cervical cancer diagnosed shortly after pregnancy: prognostic
variables and Lishner M: Cancer in pregnancy. Annals of Oncology.
14:31–36. 2003.
|
|
11
|
Lishner M: Cancer in pregnancy. Ann Oncol.
14(Suppl 3): iii31–iii36. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Abeler VM, Holm R, Nesland JM and Kjørstad
KE: Small cell carcinoma of the cervix. A clinicopathologic study
of 26 patients. Cancer. 73:672–677. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zivanovic O, Leitao MM Jr, Park KJ, et al:
Small cell neuroendocrine carcinoma of the cervix: Analysis of
outcome, recurrence pattern and the impact of platinum-based
combination chemotherapy. Gynecol Oncol. 112:590–593. 2009.
View Article : Google Scholar
|
|
14
|
Katsumata N, Yoshikawa H, Kobayashi H, et
al: Phase III randomised controlled trial of neoadjuvant
chemotherapy plus radical surgery vs radical surgery alone for
stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical
Oncology Group trial (JCOG 0102). Br J Cancer. 108:1957–1963. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chun KC, Kim DY, Kim JH, et al:
Neoadjuvant chemotherapy with paclitaxel plus platinum followed by
radical surgery in early cervical cancer during pregnancy: three
case reports. Jpn J Clin Oncol. 40:694–698. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Smyth EC, Korpanty G, McCaffrey JA, et al:
Small-cell carcinoma of the cervix at 23 weeks gestation. J Clin
Oncol. 28:e295–e297. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ohwada M, Suzuki M, Hironaka M, et al:
Neuroendocrine small cell carcinoma of the uterine cervix showing
polypoid growth and complicated by pregnancy. Gynecol Oncol.
81:117–119. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Leung TW, Lo SH, Wong SF, et al: Small
cell carcinoma of the cervix complicated by pregnancy. Clin Oncol
(R Coll Radiol). 11:123–125. 1999. View Article : Google Scholar
|
|
19
|
Balderston KD, Tewari K, Gregory WT, et
al: Neuroendocrine small cell uterine cervix cancer in pregnancy:
long-term survival following combined therapy. Gynecol Oncol.
71:128–132. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Perrin L, Bell J and Ward B: Small cell
carcinoma of the cervix of neuroendocrine rigin causing obstructed
labor. Aust N Z J Obstet Gynaecol. 36:85–87. 1995. View Article : Google Scholar
|
|
21
|
Chang DH-C, Hsueh S and Soong YK: Small
cell carcinoma of the uterine cervix with neurosecretory granules
associated with pregnancy: a case report. J Reprod Med. 39:537–540.
1994.PubMed/NCBI
|
|
22
|
Lojek MA, Fer MF, Kasselberg AG, et al:
Cushing’s syndrome with small cell carcinoma of the uterine cervix.
Am J Med. 69:140–144. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Turner WA, Gallup DG, Talledo OE, et al:
Nueroendocrine carcinoma of the uterine cervix complicated by
pregnancy: case report and review of the literature. Obstet
Gynecol. 67(3 Suppl): 80S–83S. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jacobs AJ, Marchevsky A, Gordon RE, et al:
Oat cell carcinoma of the uterine cervix in a pregnant woman
treated with cisdiamminedichloroplatinum: case report. Gynecol
Oncol. 9:405–410. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kodousek R, Gazarek F, Dusek J and Dostál
S: Malignant apudoma (argyrophil cell cancer) of the uterine cervix
in a 24-year-old woman in pregnancy. Cesk Pathol. 12:37–44.
1976.(In Czech).
|
|
26
|
Morris M, Gershenson DM, Eifel P, et al:
Treatment of small cellcarcinoma of the cervix with cisplatin.
doxorubicin and etoposide. Gynecol Oncol. 47:62–65. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sheets EE, Berman ML, Hrountas CK, et al:
Surgically treated, early stage small cell cervical carcinoma.
Obstet Gynecol. 71:10–14. 1988.PubMed/NCBI
|
|
28
|
Sehouli J, Runnebaum IB, Fotopoulou C, et
al: A randomized phase III adjuvant study in high-risk cervical
cancer: simultaneous radiochemotherapy with cisplatin (S-RC) versus
systemic paclitaxel and carboplatin followed by percutaneous
radiation (PC-R): a NOGGO-AGO Intergroup Study. Ann Oncol.
23:2259–2264. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Herod J, Burton A, Buxton J, et al: A
randomised, prospective, phase III clinical trial of primary
bleomycin, ifosfamide and cisplatin (BIP) chemotherapy followed by
radiotherapy versus radiotherapy alone in inoperable cancer of the
cervix. Ann Oncol. 11:1175–1181. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Symonds RP, Habeshaw T, Reed NS, et al:
The Scottish and Manchester randomised trial of neo-adjuvant
chemotherapy for advanced cervical cancer. Eur J Cancer.
36:994–1001. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nguyen C, Montz FJ and Bristow RE:
Management of stage I cervical cancer in pregnancy. Obstet Gynecol
Surv. 55:633–643. 2000. View Article : Google Scholar : PubMed/NCBI
|
